ISCT 2020: safety considerations for regenerative medicine products – an interview with Ivan Martin

Ivan Martin (University of Basel, Switzerland) discusses his session presented at the 2020 International Society of Cell & Gene Therapy (ISCT) Virtual Conference (28–29 May), moving to a virtual platform, and the use of real-world data in regenerative medicine. How did you go about adapting the existing meeting plans to the virtual platform?  It was not an easy process. The real planned meeting consisted of outstanding speakers and sessions, so it was painful actually to have to cut down certain planned contributions. In the end, the priority was given to the presentations that were foreseen in the plenary sessions, but most of the preconference program that was designed by the different committees of ISCT...

To view this content, please register now for access

It's completely free